Aftovaxpur DOE

RSS

Withdrawn

This medicine's authorisation has been withdrawn

inactivated vaccine against foot-and-mouth disease
MedicineVeterinaryWithdrawn

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Aftovaxpur DOE has been withdrawn at the request of the marketing authorisation holder.

español (ES) (172.3 kB - PDF)

Bekijk

eesti (ET) (162.94 kB - PDF)

Bekijk

français (FR) (174.49 kB - PDF)

Bekijk

hrvatski (HR) (200.82 kB - PDF)

Bekijk

italiano (IT) (165.88 kB - PDF)

Bekijk

latviešu (LV) (218.99 kB - PDF)

Bekijk

lietuvių (LT) (217.75 kB - PDF)

Bekijk

magyar (HU) (202.82 kB - PDF)

Bekijk

Malti (MT) (228.87 kB - PDF)

Bekijk

Nederlands (NL) (175.04 kB - PDF)

Bekijk

polski (PL) (219.81 kB - PDF)

Bekijk

português (PT) (173.64 kB - PDF)

Bekijk

română (RO) (214.89 kB - PDF)

Bekijk

slovenčina (SK) (223.99 kB - PDF)

Bekijk

slovenščina (SL) (199.83 kB - PDF)

Bekijk

suomi (FI) (166.62 kB - PDF)

Bekijk

svenska (SV) (170.28 kB - PDF)

Bekijk

Product information

български (BG) (886.49 kB - PDF)

Bekijk

español (ES) (582.68 kB - PDF)

Bekijk

čeština (CS) (660.11 kB - PDF)

Bekijk

dansk (DA) (561.16 kB - PDF)

Bekijk

Deutsch (DE) (590.71 kB - PDF)

Bekijk

eesti (ET) (590.49 kB - PDF)

Bekijk

ελληνικά (EL) (884.66 kB - PDF)

Bekijk

français (FR) (592.03 kB - PDF)

Bekijk

hrvatski (HR) (654.4 kB - PDF)

Bekijk

italiano (IT) (599.14 kB - PDF)

Bekijk

latviešu (LV) (734.82 kB - PDF)

Bekijk

lietuvių (LT) (722.56 kB - PDF)

Bekijk

magyar (HU) (663.56 kB - PDF)

Bekijk

Malti (MT) (740.29 kB - PDF)

Bekijk

Nederlands (NL) (561.3 kB - PDF)

Bekijk

polski (PL) (771.72 kB - PDF)

Bekijk

português (PT) (554.32 kB - PDF)

Bekijk

română (RO) (725.86 kB - PDF)

Bekijk

slovenčina (SK) (702.49 kB - PDF)

Bekijk

slovenščina (SL) (662.49 kB - PDF)

Bekijk

suomi (FI) (551.34 kB - PDF)

Bekijk

svenska (SV) (532.56 kB - PDF)

Bekijk

Íslenska (IS) (543.52 kB - PDF)

Bekijk

norsk (NO) (538.94 kB - PDF)

Bekijk
Latest procedure affecting product information:IG/1204/G
20/03/2020

български (BG) (807.49 kB - PDF)

Bekijk

español (ES) (1.28 MB - PDF)

Bekijk

čeština (CS) (645.24 kB - PDF)

Bekijk

dansk (DA) (627.43 kB - PDF)

Bekijk

Deutsch (DE) (685.67 kB - PDF)

Bekijk

eesti (ET) (668.12 kB - PDF)

Bekijk

ελληνικά (EL) (647.06 kB - PDF)

Bekijk

français (FR) (748.55 kB - PDF)

Bekijk

hrvatski (HR) (642.38 kB - PDF)

Bekijk

italiano (IT) (713.91 kB - PDF)

Bekijk

latviešu (LV) (714.86 kB - PDF)

Bekijk

lietuvių (LT) (615.74 kB - PDF)

Bekijk

magyar (HU) (661.6 kB - PDF)

Bekijk

Malti (MT) (779.85 kB - PDF)

Bekijk

Nederlands (NL) (669.1 kB - PDF)

Bekijk

polski (PL) (598.16 kB - PDF)

Bekijk

português (PT) (718.68 kB - PDF)

Bekijk

română (RO) (704.33 kB - PDF)

Bekijk

slovenčina (SK) (644.86 kB - PDF)

Bekijk

slovenščina (SL) (645.07 kB - PDF)

Bekijk

suomi (FI) (639.14 kB - PDF)

Bekijk

svenska (SV) (647.06 kB - PDF)

Bekijk

Íslenska (IS) (693.42 kB - PDF)

Bekijk

norsk (NO) (706.57 kB - PDF)

Bekijk

Product details

Name of medicine
Aftovaxpur DOE
Active substance
Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063.
International non-proprietary name (INN) or common name
inactivated vaccine against foot-and-mouth disease
Species
  • Pigs
  • Cattle
  • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) code
QI02AA04

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of cattle, sheep and pigs from 2 weeks of age against foot-and-mouth disease to reduce clinical signs.

Authorisation details

EMA product number
EMEA/V/C/002292
Marketing authorisation holder
Boehringer Ingelheim Vetmedica GmbH

55216 Ingelheim am Rhein
Germany

Marketing authorisation issued
15/07/2013
Revision
8

Assessment history

This page was last updated on

Share this page